CIGB

Work of Cuba’s Center for Genetic Engineering is acknowledged

Published on: July 1, 2023
09:59

Havana, Jul 1 (Prensa Latina) Cuban Prime Minister Manuel Marrero on Saturday acknowledged the work and contributions to science from the Center for Genetic Engineering and Biotechnology (CIGB), on the occasion of the 37th anniversary of its creation.

President Díaz-Canel praises advances in dengue vaccine candidate

Published on: March 21, 2023
18:11

Havana, Mar 21 (Prensa Latina) Cuban President Miguel Díaz-Canel on Tuesday praised progress achieved in creating new dengue vaccine candidate developed by the Center for Genetic Engineering and Biotechnology (CIGB).

Cuba’s dengue vaccine candidate based on recombinant proteins

Published on: March 21, 2023
16:15

Havana, Mar 21 (Prensa Latina) Cuba´s vaccine candidate to treat dengue has a safe technological platform, as informed by the Center for Genetic Engineering and Biotechnology (CIGB).

Cuba’s Abdala vaccine is safe, effective and thermostable – CIGB

Published on: February 9, 2023
16:43

Havana, Feb 9 (Prensa Latina) Cuba's Covid-19 Abdala vaccine proved to be stable, effective and functional after being stored for 15 days at 37oC, the Center for Genetic Engineering and Biotechnology of Cuba (CIGB) reported Thursday.

Cuban President praises Covid-19 immunization progress

Published on: January 11, 2023
15:45

Havana, Jan 11 (Prensa Latina) Cuban President Miguel Díaz-Canel on Wednesday praised his country's progress in domestic Covid-19 immunization thanks to homegrown vaccine development.

Cuba to ramp up Jusvinza anti-Covid-19 drug production

Published on: October 4, 2021
07:59

Havana, Oct 4 (Prensa Latina) The Center for Genetic Engineering and Biotechnology (CIGB) on Sunday highlighted that new Jusvinza drug is Cuba's first therapeutic product based on synthetic peptide, so its production is expected to ramp up.

CECMED authorizes to use phase-II trial with CIGB2020 candidate

Published on: August 12, 2021
07:36

Havana, Aug 12 (Prensa Latina) Cuba´s Center for State Control of medicines, Equipment and Medical Devices (CECMED) on Wednesday authorized the start of a phase-II clinical trial with the vaccine candidate CIGB2020, seeking to stimulate the immune response against acute respiratory infections.

CIGB, 35 years of history written with scientific innovation

Published on: July 1, 2021
09:01

Havana, Jul 1 (Prensa Latina) The fundamental characteristic of the CIGB, which marks 35 years this Thursday, lies in its new products, Dr. Gerardo Guillen, Director of Biomedical Research, told exclusively Prensa Latina.

NEWS